Bionomics (BNOX) Competitors $0.19 -0.01 (-4.97%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BNOX vs. FBRX, VCNX, ADIL, AEZS, ONVO, PRTG, MBRX, ERNA, CDIO, and ORGSShould you be buying Bionomics stock or one of its competitors? The main competitors of Bionomics include Forte Biosciences (FBRX), Vaccinex (VCNX), Adial Pharmaceuticals (ADIL), Aeterna Zentaris (AEZS), Organovo (ONVO), Portage Biotech (PRTG), Moleculin Biotech (MBRX), Eterna Therapeutics (ERNA), Cardio Diagnostics (CDIO), and Orgenesis (ORGS). These companies are all part of the "pharmaceutical products" industry. Bionomics vs. Forte Biosciences Vaccinex Adial Pharmaceuticals Aeterna Zentaris Organovo Portage Biotech Moleculin Biotech Eterna Therapeutics Cardio Diagnostics Orgenesis Bionomics (NASDAQ:BNOX) and Forte Biosciences (NASDAQ:FBRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability. Is BNOX or FBRX more profitable? Bionomics' return on equity of 0.00% beat Forte Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets BionomicsN/A N/A N/A Forte Biosciences N/A -117.85%-98.67% Does the media refer more to BNOX or FBRX? In the previous week, Forte Biosciences had 2 more articles in the media than Bionomics. MarketBeat recorded 2 mentions for Forte Biosciences and 0 mentions for Bionomics. Forte Biosciences' average media sentiment score of 0.32 beat Bionomics' score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Bionomics Neutral Forte Biosciences Neutral Does the MarketBeat Community believe in BNOX or FBRX? Forte Biosciences received 8 more outperform votes than Bionomics when rated by MarketBeat users. However, 76.00% of users gave Bionomics an outperform vote while only 58.70% of users gave Forte Biosciences an outperform vote. CompanyUnderperformOutperformBionomicsOutperform Votes1976.00% Underperform Votes624.00% Forte BiosciencesOutperform Votes2758.70% Underperform Votes1941.30% Do institutionals and insiders believe in BNOX or FBRX? 15.9% of Bionomics shares are held by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are held by institutional investors. 1.5% of Bionomics shares are held by company insiders. Comparatively, 9.6% of Forte Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, BNOX or FBRX? Bionomics has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500. Do analysts recommend BNOX or FBRX? Bionomics presently has a consensus target price of $8.00, suggesting a potential upside of 4,187.25%. Forte Biosciences has a consensus target price of $3.25, suggesting a potential downside of 24.94%. Given Bionomics' higher possible upside, analysts plainly believe Bionomics is more favorable than Forte Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionomics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, BNOX or FBRX? Bionomics has higher revenue and earnings than Forte Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionomics$10K329.43-$15.49MN/AN/AForte BiosciencesN/AN/A-$31.48M-$18.25-0.24 SummaryForte Biosciences beats Bionomics on 7 of the 13 factors compared between the two stocks. Ad Porter & CompanyRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Get Bionomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNOX vs. The Competition Export to ExcelMetricBionomicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.29M$6.74B$5.02B$8.44BDividend YieldN/A7.94%7.49%4.16%P/E RatioN/A11.61127.0816.62Price / Sales329.43289.441,683.1877.41Price / CashN/A46.0936.9033.53Price / Book0.145.284.585.21Net Income-$15.49M$150.62M$113.81M$223.74M7 Day Performance-2.11%0.30%111.02%2.82%1 Month Performance-33.47%16.75%125.11%8.93%1 Year Performance-92.45%37.44%155.23%29.44% Bionomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNOXBionomics2.1579 of 5 stars$0.19-5.0%$8.00+4,083.2%-92.2%$3.31M$10,000.000.00N/ANews CoverageHigh Trading VolumeFBRXForte Biosciences1.5484 of 5 stars$4.58-0.9%$3.25-29.0%+21,670.8%$6.75MN/A-0.255Upcoming EarningsVCNXVaccinex1.373 of 5 stars$3.79+1.3%N/A-77.3%$6.55M$356,000.00-0.0640Upcoming EarningsHigh Trading VolumeADILAdial Pharmaceuticals0.7251 of 5 stars$1.02-1.9%N/A-55.3%$6.53MN/A0.0020Positive NewsAEZSAeterna Zentaris1.1817 of 5 stars$3.61-3.0%$60.00+1,562.9%-39.5%$6.47M$2.37M-0.2420News CoverageGap UpONVOOrganovo0.1843 of 5 stars$0.45+4.7%N/A-72.6%$6.40M$73,000.00-0.3220Analyst ForecastPRTGPortage Biotech1.6299 of 5 stars$5.95+2.6%$120.00+1,916.8%-85.8%$6.25MN/A-0.136Positive NewsMBRXMoleculin Biotech1.8857 of 5 stars$2.62flat$35.00+1,235.9%-68.0%$6.06MN/A0.0020Upcoming EarningsPositive NewsERNAEterna Therapeutics0.234 of 5 stars$1.10+7.8%N/A-20.6%$5.95M$70,000.00-0.2510Upcoming EarningsCDIOCardio Diagnostics3.0907 of 5 stars$0.26-16.2%$2.00+671.6%-30.6%$5.88M$39,138.000.007Upcoming EarningsGap DownHigh Trading VolumeORGSOrgenesis2.7306 of 5 stars$1.17-4.9%N/AN/A$5.62M$530,000.000.00150Upcoming EarningsNews CoverageGap Up Related Companies and Tools Related Companies FBRX Competitors VCNX Competitors ADIL Competitors AEZS Competitors ONVO Competitors PRTG Competitors MBRX Competitors ERNA Competitors CDIO Competitors ORGS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BNOX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
